LLY FDA grants traditional approval to selpercatinib for locally advanced or metastatic ret Fusion-positive solid tumors
LLY FDA grants traditional approval to selpercatinib for locally advanced or metastatic ret Fusion-positive solid tumors
Story updates
06:21:34 PM UTC
SquawkNews
Retevmo granted FDA traditional approval for RET fusion-positive solid tumors
LLY FDA grants traditional approval to selpercatinib for locally advanced or metastatic ret Fusion-positive solid tumors